Key facts
- It has raised $55.1M; the latest was Later Stage VC ($35.0M) in Sep 2024.
- Notable investors include Bpifrance, European Commission, Astanor, Lombard Odier, Lombard Odier Investment Managers — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Calyxia
- ·The full record, as it builds
Funding rounds
No funding rounds for Calyxia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Calyxia
Manufacturer of customizable and biodegradable microcapsules intended to protect active ingredients during industrial processes. The company produces tailor-made microcapsules for application-specific industrial use cases that contain and protect ingredients against all forms of degradation and deliver at the optimum time and site for higher performance, enabling companies in advanced materials, sustainable agriculture, and home care industries to create newly formulated products with fewer ingredients and better performance features.
- Sector
- Business Products and Services (B2B)
- HQ
- Limeil Brevannes, France
- Founded
- 2015
- Employees
- 107
- Website
- calyxia.com/
- Ownership
- Privately Held (backing)
Calyxia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Calyxia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Calyxia in its N-PORT filings yet. We sweep new filings monthly.